Inactive Instrument
Oragenics Inc Stock OTC Bulletin Board
Stocks
OGEN
US6840232036
Biotechnology & Medical Research
| Market Cap | 776K 707K 655K 592K 1.11M 72.48M 1.16M 7.91M 3.14M 39.17M 2.91M 2.85M 124M | P/E 2024 |
-0.23x | P/E 2025 | -0.17x |
|---|---|---|---|---|---|
| Enterprise Value | -7.4M -6.74M -6.24M -5.64M -10.59M -691M -11.08M -75.4M -29.91M -373M -27.75M -27.17M -1.18B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
98.07% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Janet Huffman
CEO | Chief Executive Officer | 54 | 16/12/2024 |
John Spencer
DFI | Director of Finance/CFO | 32 | 01/07/2026 |
William Peacock
CTO | Chief Tech/Sci/R&D Officer | 67 | 22/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Koski
BRD | Director/Board Member | 67 | 30/06/2009 |
Charles Pope
CHM | Chairman | 74 | 16/12/2022 |
| Chairman | 74 | 04/02/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 776K | ||
| +0.19% | -3.96% | +54.92% | +69.15% | 65.42B | ||
| -0.68% | -2.96% | +6.15% | +89.13% | 58.91B | ||
| -1.17% | -0.87% | +24.57% | +84.83% | 55.24B | ||
| -0.97% | -3.91% | +12.98% | +113.88% | 45.66B | ||
| -2.83% | -7.58% | +15.21% | +22.34% | 41.29B | ||
| +3.61% | +2.63% | +21.96% | +46.39% | 36.82B | ||
| -0.24% | -9.59% | +126.05% | +647.44% | 34.48B | ||
| +0.07% | +1.36% | +78.59% | +57.43% | 32.5B | ||
| +20.58% | +22.35% | -29.03% | +482.03% | 31.69B | ||
| Average | +1.85% | -0.39% | +34.60% | +179.18% | 45B | |
| Weighted average by Cap. | +1.31% | -0.98% | +33.14% | +153.63% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -10.57M -9.63M -8.91M -8.06M -15.12M -987M -15.83M -108M -42.74M -533M -39.65M -38.82M -1.69B | -9.84M -8.97M -8.3M -7.51M -14.09M -919M -14.74M -100M -39.8M -497M -36.93M -36.15M -1.57B |
| Net Debt | -536K -489K -452K -409K -768K -50.09M -803K -5.47M -2.17M -27.07M -2.01M -1.97M -85.74M | -8.17M -7.45M -6.89M -6.23M -11.7M -763M -12.24M -83.32M -33.05M -412M -30.66M -30.02M -1.31B |
Employees
-
















